Hypoxia-Inducible Factor 1α Stability Modified by Glutaredoxin-1 in Necrotizing Enterocolitis

Area of Science:

• Gastroenterology
• Neonatal Research
• Molecular Biology

Background:

• Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease in neonates.
• Hypoxia-inducible factor-1α (HIF-1α) plays a critical role in NEC pathogenesis.
• The specific role of HIF-1α in intestinal microcirculation during NEC is not fully understood.

Purpose of the Study:

• To investigate the role of HIF-1α in regulating intestinal microcirculation during NEC development.
• To determine the impact of glutaredoxin-1 (Grx1) deletion on HIF-1α activity and intestinal microcirculation in a mouse model of NEC.

Main Methods:

• Experimental NEC was induced in C57BL/6 and Grx1 knockout (Grx1-/-) mice.
• HIF-1α signaling was inhibited using the specific inhibitor YC-1.
• Intestinal microcirculation, HIF-1α activity, and signaling pathways were assessed.

Main Results:

• NEC induction led to impaired intestinal microcirculation, characterized by reduced blood flow and capillary density.
• Grx1 deletion ameliorated microcirculatory impairment in NEC, associated with increased vascular endothelial growth factor A (VEGF-A) production.
• Inhibition of HIF-1α abolished the protective effects observed in Grx1-/- mice, indicating HIF-1α's involvement in microvascular regulation.

Conclusions:

• HIF-1α signaling is a key mediator of intestinal microvascular changes in NEC.
• Targeting HIF-1α presents a potential therapeutic strategy for managing NEC.
• Grx1 deletion may offer protection against NEC-induced intestinal injury through HIF-1α-dependent mechanisms.